Curium deepens radiopharma heft with up to $8 billion deal for Lantheus
By Kamal Choudhury and Kunal Das Aug 3 (Reuters) – Radiopharmaceutical company Curium has agreed to buy peer Lantheus Holdings in a deal worth up to $8 ābillion, as the private equity-backed firm looks to expand its footprint in āthe fast-growing sector. Radiopharmaceuticals, which use radioactive compounds to diagnose and treat diseases such as cancer,…
